{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:25:38Z","timestamp":1770956738784,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.peptides.2017.04.007","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T22:47:29Z","timestamp":1492901249000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Extracellular NAMPT\/Visfatin induces proliferation through ERK1\/2 and AKT and inhibits apoptosis in breast cancer cells"],"prefix":"10.1016","volume":"92","author":[{"given":"Zafar","family":"Gholinejad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nejat","family":"kheiripour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitra","family":"Nourbakhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davod","family":"Ilbeigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiarash","family":"Behroozfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Hesari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolfazl","family":"Golestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Einollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2017.04.007_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.peptides.2017.04.007_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/0008-5472.CAN-09-2257","article-title":"Obesity and breast cancer: progress to understanding the relationship","volume":"70","author":"Brown","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.peptides.2017.04.007_bib0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1677\/ERC-06-0068","article-title":"Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression","volume":"14","author":"Vona-Davis","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.peptides.2017.04.007_bib0020","doi-asserted-by":"crossref","first-page":"e78283","DOI":"10.1371\/journal.pone.0078283","article-title":"Visfatin as a novel mediator released by inflamed human endothelial cells","volume":"8","author":"Romacho","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2017.04.007_bib0025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00125-006-0173-z","article-title":"Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin","volume":"49","author":"Curat","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2017.04.007_bib0030","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1463-1326.2006.00625.x","article-title":"Visfatin expression is hormonally regulated by metabolic and sex hormones in 3t3-l1 pre-adipocytes and adipocytes Diabetes","volume":"9","author":"MacLaren","year":"2007","journal-title":"Obes. Metab."},{"key":"10.1016\/j.peptides.2017.04.007_bib0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/1947601913507576","article-title":"Nicotinamide phosphoribosyltransferase in malignancy: a review","volume":"4","author":"Shackelford","year":"2013","journal-title":"Genes Cancer"},{"key":"10.1016\/j.peptides.2017.04.007_bib0040","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1158\/1055-9965.EPI-11-0399","article-title":"High visfatin expression in breast cancer tissue is associated with poor survival","volume":"20","author":"Lee","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prevent."},{"key":"10.1016\/j.peptides.2017.04.007_bib0045","doi-asserted-by":"crossref","DOI":"10.1507\/endocrj.EJ16-0448","article-title":"Circulating leptin, soluble leptin receptor, free leptin index, visfatin and selected leptin and leptin receptor gene polymorphisms in sporadic breast cancer","author":"Rodrigo","year":"2017","journal-title":"Endocr. J."},{"key":"10.1016\/j.peptides.2017.04.007_bib0050","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3892\/or.2015.4391","article-title":"Biomarker triplet nampt\/vegf\/her2 as a de novo detection panel for the diagnosis and prognosis of human breast cancer","volume":"35","author":"Zhu","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.peptides.2017.04.007_bib0055","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.orcp.2015.08.017","article-title":"Evaluation of diagnostic and predictive value of serum adipokines: leptin, resistin and visfatin in postmenopausal breast cancer","volume":"10","author":"Assiri","year":"2016","journal-title":"Obes. Res. Clin. Pract."},{"key":"10.1016\/j.peptides.2017.04.007_bib0060","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/gme.0b013e31821e21f5","article-title":"Elevated serum visfatin\/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters","volume":"18","author":"Dalamaga","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.peptides.2017.04.007_bib0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2011.09.014","article-title":"Visfatin induces neurite outgrowth in pc12 cells via erk1\/2 signaling pathway","volume":"504","author":"Kang","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.peptides.2017.04.007_bib0070","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.18632\/oncotarget.2086","article-title":"Visfatin promotes cell and tumor growth by upregulating notch1 in breast cancer","volume":"5","author":"Park","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.peptides.2017.04.007_bib0075","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrendo.2015.117","article-title":"Physiological and pathophysiological roles of nampt and nad metabolism","volume":"11","author":"Garten","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.peptides.2017.04.007_bib0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1023781114568","article-title":"Role of map kinase in tumor progression and invasion","volume":"22","author":"Reddy","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.peptides.2017.04.007_bib0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/bcr2361","article-title":"Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development","volume":"11","author":"Whyte","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.peptides.2017.04.007_bib0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2325\/jbcs.13.137","article-title":"Activation of pi3k\/akt signaling and hormone resistance in breast cancer","volume":"13","author":"Tokunaga","year":"2006","journal-title":"Breast Cancer"},{"key":"10.1016\/j.peptides.2017.04.007_bib0095","doi-asserted-by":"crossref","first-page":"10792","DOI":"10.1074\/jbc.273.17.10792","article-title":"The activation of p38 and apoptosis by the inhibition of erk is antagonized by the phosphoinositide 3-kinase\/akt pathway","volume":"273","author":"Berra","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2017.04.007_bib0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccr.2005.08.008","article-title":"The akt-mtor tango and its relevance to cancer","volume":"8","author":"Hay","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.peptides.2017.04.007_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","article-title":"Apoptosis in cancer: from pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.peptides.2017.04.007_bib0110","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1582-4934.2005.tb00361.x","article-title":"Survivin as a target for new anticancer interventions","volume":"9","author":"Zaffaroni","year":"2005","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.peptides.2017.04.007_bib0115","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.4161\/cc.8.17.9457","article-title":"Survivin as a global target of intrinsic tumor suppression networks","volume":"8","author":"Guha","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.peptides.2017.04.007_bib0120","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.biocel.2013.06.026","article-title":"Survivin up-regulates the expression of breast cancer resistance protein (bcrp) through attenuating the suppression of p53 on nf-\u03bab expression in mcf-7\/5-fu cells","volume":"45","author":"Q-p","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.peptides.2017.04.007_bib0125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jcp.24257","article-title":"A novel adipocytokine visfatin protects against h(2)o(2) \u2212induced myocardial apoptosis: a missing link between obesity and cardiovascular disease","volume":"228","author":"Xiao","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.peptides.2017.04.007_bib0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/JME-10-0106","article-title":"Visfatin inhibits apoptosis of pancreatic \u03b2-cell line, min6, via the mitogen-activated protein kinase\/phosphoinositide 3-kinase pathway","volume":"47","author":"Cheng","year":"2011","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.peptides.2017.04.007_bib0135","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0165-6147(00)01902-7","article-title":"Poly (adp-ribose) polymerase: killer or conspirator? the \u2018suicide hypothesis\u2019 revisited","volume":"23","author":"Chiarugi","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.peptides.2017.04.007_bib0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.2012.06750.x","article-title":"Obesity and cancer risk: evidence, mechanisms, and recommendations","volume":"1271","author":"Vucenik","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.peptides.2017.04.007_bib0145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-0029-1241870","article-title":"Obesity and cancer","volume":"117","author":"Percik","year":"2009","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.peptides.2017.04.007_bib0150","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1158\/1055-9965.EPI-11-0399","article-title":"High visfatin expression in breast cancer tissue is associated with poor survival","volume":"20","author":"Lee","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.peptides.2017.04.007_bib0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/00365513.2014.1003594","article-title":"Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome","volume":"75","author":"Nourbakhsh","year":"2015","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.peptides.2017.04.007_bib0160","doi-asserted-by":"crossref","first-page":"253519","DOI":"10.1155\/2015\/253519","article-title":"Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers","volume":"2015","author":"Assiri","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.peptides.2017.04.007_bib0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.maturitas.2011.12.013","article-title":"Could serum visfatin be a potential biomarker for postmenopausal breast cancer","volume":"71","author":"Dalamaga","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.peptides.2017.04.007_bib0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.peptides.2013.11.010","article-title":"Preoperative serum visfatin levels and prognosis of breast cancer among chinese women","volume":"51","author":"Li","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2017.04.007_bib0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10059-010-0124-x","article-title":"Visfatin stimulates proliferation of mcf-7 human breast cancer cells","volume":"30","author":"Kim","year":"2010","journal-title":"Mol. Cells"},{"key":"10.1016\/j.peptides.2017.04.007_bib0180","article-title":"Extracellular visfatin-promoted malignant behavior in breast cancer is mediated through c-abl and stat3 activation","author":"Hung","year":"2016","journal-title":"Am. Assoc. Cancer Res."},{"key":"10.1016\/j.peptides.2017.04.007_bib0185","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.18632\/oncotarget.2086","article-title":"Visfatin promotes cell and tumor growth by upregulating notch1 in breast cancer","volume":"5","author":"Park","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.peptides.2017.04.007_bib0190","doi-asserted-by":"crossref","first-page":"34189","DOI":"10.1074\/jbc.M114.594721","article-title":"Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity","volume":"289","author":"Soncini","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2017.04.007_bib0195","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2008.11.024","article-title":"Pre-b cell colony enhancing factor (pbef)\/visfatin induces secretion of mcp-1 in human endothelial cells: role in visfatin-induced angiogenesis","volume":"205","author":"Adya","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.peptides.2017.04.007_bib0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbrc.2007.03.105","article-title":"Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1\/2","volume":"357","author":"Kim","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2017.04.007_bib0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.peptides.2009.10.001","article-title":"A novel role for the adipokine visfatin\/pre-b cell colony-enhancing factor 1 in prostate carcinogenesis","volume":"31","author":"Patel","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2017.04.007_bib0210","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/carcin\/20.7.1201","article-title":"Altered map kinase (erk1,2) regulation in primary cultures of mammary tumor cells: elevated basal activity and sustained response to egf","volume":"20","author":"Xing","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.peptides.2017.04.007_bib0215","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1038\/sj.onc.1205555","article-title":"Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 mapk in mediating cell cycle progression of breast cancer cells","volume":"21","author":"Neve","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.peptides.2017.04.007_bib0220","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/bcr2883","article-title":"Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the mapk\/erk and pi3k\/akt signaling routes","volume":"13","author":"Zhang","year":"2011","journal-title":"Breast Cancer Res.: BCR"},{"key":"10.1016\/j.peptides.2017.04.007_bib0225","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1289\/ehp.1104051","article-title":"Effects of decabrominated diphenyl ether (pbde-209) in regulation of growth and apoptosis of breast, ovarian, and cervical cancer cells","volume":"120","author":"Li","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.peptides.2017.04.007_bib0230","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1386-6346(03)00112-8","article-title":"Erk\/mapk-dependent pi3k\/akt phosphorylation through vegfr-1 after vegf stimulation in activated hepatic stellate cells","volume":"26","author":"Takahashi","year":"2003","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.peptides.2017.04.007_bib0235","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/cns.12273","article-title":"Extracellular visfatin has nicotinamide phosphoribosyltransferase enzymatic activity and is neuroprotective against ischemic injury","volume":"20","author":"Zhao","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.peptides.2017.04.007_bib0240","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10989-014-9449-1","article-title":"Visfatin inhibits apoptosis and necrosis of hippocampus ca3 cells following transient global ischemia\/reperfusion in rats","volume":"21","author":"Erfani","year":"2015","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.peptides.2017.04.007_bib0245","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3892\/mmr.2014.2204","article-title":"Expression of microrna-26b, an obesity-related microrna, is regulated by free fatty acids, glucose, dexamethasone and growth hormone in human adipocytes","volume":"10","author":"Xu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.peptides.2017.04.007_bib0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molcel.2008.03.008","article-title":"Iaps What's in a name?","volume":"30","author":"Srinivasula","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.peptides.2017.04.007_bib0255","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1007\/s13277-015-3506-z","article-title":"Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin\/survivin dex3 expression","volume":"36","author":"Sawicka-Gutaj","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.peptides.2017.04.007_bib0260","doi-asserted-by":"crossref","first-page":"e2058","DOI":"10.1038\/cddis.2015.275","article-title":"Potential of apoptotic pathway-targeted cancer therapeutic research: where do we stand[quest]","volume":"7","author":"Baig","year":"2016","journal-title":"Cell. Death. Dis."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978117301778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978117301778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T13:03:54Z","timestamp":1569071034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978117301778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":52,"alternative-id":["S0196978117301778"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2017.04.007","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular NAMPT\/Visfatin induces proliferation through ERK1\/2 and AKT and inhibits apoptosis in breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2017.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}